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Abstract: The last step in the biosynthesis of flavin adenine dinucleotide (FAD) is considered a target
for the design of antimicrobial drugs because it is carried out by two non-homologous proteins in
eukaryotic and prokaryotic organisms. Monofunctional FMN: adenylyltransferases (FMNAT) in
Eukarya and FMNAT modules of bifunctional FAD synthases (FADS) in Prokarya belong to different
structural families with dissimilar chemistry and binding modes for the substrates. In this study, we
analyzed the relevance of the hydrophobic environment of the flavin isoalloxazine in the FMNAT
active site of Corynebacterium ammoniagenes FADS (CaFADS) through the mutational analysis of its F62,
Y106, and F128 residues. They form the isoalloxazine binding cavity and are highly conserved in the
prokaryotic FADS family. The spectroscopic, steady-state kinetics and thermodynamic data presented
indicate that distortion of aromaticity at the FMNAT isoalloxazine binding cavity prevents FMN
and FAD from correct accommodation in their binding cavity and, as a consequence, decreases the
efficiency of the FMNAT activity. Therefore, the side-chains of F62, Y106 and F128 are relevant in the
formation of the catalytic competent complex during FMNAT catalysis in CaFADS. The introduced
mutations also modulate the activity occurring at the riboflavin kinase (RFK) module of CaFADS,
further evidencing the formation of quaternary assemblies during catalysis.
Keywords: flavin biosynthesis; prokaryotic FAD synthase; eukaryotic ATP:FMN:adenylyltransferase;
aromatic residues; isoalloxazine; binding; rational mutagenesis; isothermal titration calorimetry;
steady-state kinetics
1. Introduction
The biosynthesis of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) is
considered a potential drug target for the search of new antimicrobials [1–3]. This is due to these flavin
cofactors being essential for numerous flavoenzyme-catalyzed reactions, including protein folding,
electron transport in the respiratory and photosynthetic chains, β-oxidation of fatty acids, nucleotide
synthesis, or signal transduction among others [4,5]. All organisms synthesize FMN and FAD from
riboflavin (RF) by the sequential action of two enzymatic activities, an ATP: riboflavinkinase (RFK) (EC
2.7.1.26), and an ATP: FMN adenylyltransferase (FMNAT) (EC 2.7.7.2) (Figure 1a). In prokaryotes, these
two activities reside in a bifunctional enzyme named FAD synthase (FADS), consisting of an FMNAT
module at the N-terminal and an RFK module at the C-terminal. By contrast, in most eukaryotes,
two independent enzymes catalyze the production of FMN from RF, or of FAD from FMN [1,6].
The RFK module of prokaryotic FADSs shares sequence and structural homology with eukaryotic
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RFKs, but species-specific features have been recently reported [7–10]. By contrast, the FMNAT
module differs from eukaryotic FMNATs (also known as FADSs) in sequence and structure. Although
both adopt a Rossmann α/β/α topology, they belong to different protein families. While eukaryotic
FMNATs with a 3-phosphoadenosine 5′-phosphosulfate (PAPS) reductase module belong to the
adenine dinucleotide α-hydrolase-like superfamily [6,11], the FMNAT modules of prokaryotic FADSs
belong to the nucleotidylyl transferase superfamily [7,9] (Figure 1b).
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Structural information of eukaryotic FADSs is available for the yeasts Candida glabrata (CgFMNAT),
free and in complex with the FMN substrate, and an ATP analog as well as with FAD [6], and
Saccharomyces cerevisiae (ScFMNAT), which is, in this case, in a complex with FAD [11]. In Homo Sapiens,
up to six FADSs isoforms (HsFADS) have been identified as a result of alternative splicing of the same
gene. The three longest isoforms contain, in addition to the PAPS reductase module, a molybdopterin
binding-like module responsible for FAD hydrolase activity, not present in yeast FADSs. Two isoforms
lack the PAPS reductase module while the last isoform discovered lacks the FAD hydrolase module. In
addition, these isoforms also differ in subcellular location as well as in catalytic efficiencies and ions
requirements [13–18]. There are no crystallographic structures available for any of these HsFADSs,
but some structural models have been built [17,19,20]. Lastly, a potential variety of mechanisms for
regulation of FAD ho eostasis in eukaryotic FADS might be occurring, as seen by the direct transfer of
FAD from FADS to the client-apoproteins in human cells [21] or the product inhibition of the FMNAT
activity reported in rat liver [22].
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In prokaryotic FADSs, several members of the family, namely Corynbacterium ammoniagenes
(CaFADS), Streptococcus pneumoniae (SpFADS), and Listeria monocytogenes (LmFADS), are being
thoroughly characterized [23–26]. Differential features among species are claimed to control FMN and
FAD biosynthesis and homeostasis, such as stabilization of quaternary assemblies, redox requirements
for RFK and FMNAT activities, and/or cooperativity in the binding of a substrate and products.
Available crystallographic structures are those from Thermotoga maritima, S. pneumoniae (PDB 3op1), and
C. ammoniagenes [27,28]. In addition, X-ray structures of the RFK module of CaFADS in a complex with
the products of this activity are also reported [9], and models for the interaction of substrates and/or
products at the FMNAT module are built using docking and molecular dynamics simulations [12].
Mutational analysis in CaFADS have identified residues in its FMNAT module involved in catalysis
and stabilization of ATP and FMN substrates. These studies have shown that: i) the competent binding
of substrates is carefully driven by the side-chains of R161, S164, and T165 though interactions with the
phosphates of FMN and ATP, ii) the binding site for competent interaction of the FMN isoalloxazine is
shaped by conserved P56, P58, and L98 residues and iii) the adenine moiety of ATP is accommodated
by H28 together with H31, while N125 approaches the reactant atoms of ATP and FMN acting as the
FMNAT catalytic residue [29,30]. Moreover, while a hydrophobic environment coats the isoalloxazine
cavity at the FMNAT module in CaFADS, two charged residues, which are highly conserved in the
family, are key for FMN binding to CgFMNAT (Figure 1c,d and Figure 2). The hydrophobic cluster
appears highly conserved in the prokaryotic FADS family (Figure 2a), which suggests a relevant role in
the flavin catalytic competent orientation. In the present work, we studied the relevance of some of
these hydrophobic residues, particularly F62, Y106, and F128, through their substitution by alanine
(eliminating aromaticity), lysine (altering the residue nature), or tryptophan (increasing the residue
volume while keeping aromaticity). The effects of these mutations in ligand biding and catalytic
activity revealed the key role of the aromaticity at the FMNAT active site for the competent binding of
the flavinic substrates/products, which is an essential feature for the adenylylation reaction to occur.
These results, together with previous studies, provide a complete characterization of key residues at
the binding site of substrates for FMNAT catalysis in the prokaryotic CaFADS model.
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Figure 2. Sequ nc onservation at the F binding site in prokaryotic FADS and eukaryotic
FMNAT families. Sequence conservation plotted on (a) CaFADS (PDB 2x0k) an on ( ) gF AT (PDB
3g5a) structures, showing active site for the FMNAT activity (left) and key residues for the binding
of substrates/products highlighted as sticks (right). FMN and ATP:Mg2+ substrates in (a) docked
according to Reference [12]. The conservation plot was produced by the ConSurf server [31] and drawn
with PyMol [32].
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2. Results
2.1. Substitutions at F62, Y106, and F128 Produce Local Structural Changes
All CaFADS variants were purified to homogeneity with similar expression levels to the wild-type
(WT) enzyme, yielding ~10–15 mg of protein per g of wet cells (Figure S1a). Their correct folding was
assessed by UV-visible spectrophotometry and circular dichroism (CD). UV-visible spectra showed a
single maximum at 279 nm for all variants (Figure S1b). Nonetheless, while the determined extinction
coefficient value for the WT enzyme was in accordance with the theoretical one (a difference of ~0.4%),
values for the variants where, in general, their theoretical values are larger (up to 10% and 24% for
Y106A and Y106K, respectively) (Table S1). The extinction coefficient values for the folded variants
increased with regard to the WT protein. This effect was expected for those variants with an additional
tryptophan, but such a feature was also observed for other substitutions. These observations indicate
that the introduced mutations modulate the electronic environment of at least one nearby tryptophan.
Far-UV circular dichroism (CD) spectra for the WT enzyme showed a minimum at 208 nm (α-helix,
~47%) and a shoulder at 222 nm (due to β-sheet, ~21%). In general, the variants showed similar far-UV
CD spectra. Only variants at F62 showed a difference in the relative magnitude between the minima at
208 and 222 nm (Figure 3a), which suggested a decrease in the percentage of helix content (35%–40%)
(Figure S2). Most of the mutations modify the magnitude of the near-UV CD spectra, which is in
accordance with the modification of aromatic residues. This suggests changes in the local conformation
of some tryptophan around the mutated residue (Figure 3b). Therefore, the introduced mutations do
not alter the protein overall folding, but modulate the conformation of neighboring residues.
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Figure 3. Conformation of CaFADS variants. CD spectra (a) in the far-UV region (molar ellipticity per
residue) and (b) in the near-UV region (molar ellipticity) for the different CaFADS variants. Spectra
were recorded respectively in 5 mM and 20 mM PIPES, 10 mM MgCl2, pH 7.0 at 25 ◦C.
2.2. The Hydrophobic Core at the Isoalloxazine FMNAT site is Essential for FMNAT Activity and Influences
the RFK Activity
An estimation of the ability of the different variants to catalyze the transformation of RF and FMN
was performed by incubating the substrates with the enzyme for 30 min or 2 h and resolving reaction
products using thin layer chromatography (TLC) (Figure 4).
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We then determined the RFK kinetic parameters by quantifying FMN and FAD, which are products
of the conversion of RF, as a function of time when varying substrate concentrations. The absence
of FAD detection in the chromatographic profiles for variants containing alanine or lysine mutations
confirmed their lack of FMNAT activity. Increasing concentrations of RF produced an important
inhibition of the RFK activity for WT CaFADS [34] with a ratio KmRF/Ki of 2.4. This inhibition has
been attributed not only to the RF substrate inhibition but also to the reaction products, ADP and
FMN, acting as competitive and uncompetitive inhibitors, respectively. Noticeably, such inhibition
was considerably milder in the analyzed variants (with Ki >> KmRF), especially for F62A, F62K, and
F128K, which showed Ki values considerably higher than that of the WT CaFADS (Table 2 and Figure
S3b, left). Moreover, all mutations decreased kcat values but, with the exception of F62W and F128W,
showed higher catalytic efficiencies for RF due to lower KmRF values. The profiles for the RFK activity
upon increasing concentrations of ATP followed a Michaelis-Menten model, as for the WT CaFADS. In
this case, the kcat decreased for the variants, which resulted in lower catalytic efficiencies, except for
F62A and F62K where increased in kcat/KmATP were observed as a consequence of a decrease in KmATP
(Table 2 and Figure S3b, right). Therefore, the hydrophobic core of the isoalloxazine binding cavity of
the FMNAT module of CaFADS influences the RFK catalytic mechanism at the contiguous module of
the enzyme.
Table 2. Steady-state kinetic parameters for the riboflavinkinase (RFK) activity of CaFADS variants.
















WT a 408 ± 230 12 ± 3 4.9 ± 3.9 35 ± 22 155 ± 5 28 ± 4 5.5 ± 0.8
F62A 284 ± 31 2.5 ± 0.7 67 ± 22 1115 ± 33 127 ± 1 14 ± 1 9.3 ± 0.6
F62K 131 ± 3 0.2 ± 0.1 451 ± 131 534 ± 70 138 ± 5 18 ± 3 7.6 ± 1.2
F62W 151 ± 36 4.4 ± 1.8 20 ± 9 34 ± 16 92 ± 2 18 ± 2 5.2 ± 0.5
Y106A 143 ± 20 2.5 ± 0.8 34 ± 11 58 ± 19 53 ± 2 29 ± 4 1.8 ± 0.3
Y106K 148 ± 23 2.1 ± 0.7 23 ± 7 71 ± 26 54 ± 2 39 ± 6 1.4 ± 0.2
Y106W 42 ± 7 0.6 ± 0.3 34 ± 16 68 ± 37 21 ± 1 49 ± 7 0.4 ± 0.1
F128A 105 ± 20 2.6 ± 1.1 37 ± 18 40 ± 19 35 ± 1 30 ± 5 1.2 ± 0.2
F128K 68 ± 7 1.7 ± 0.5 98 ± 43 40 ± 12 51 ± 2 30 ± 4 1.7 ± 0.3
F128W 125 ± 24 4.3 ± 1.4 21 ± 8 29 ± 11 70 ± 2 38 ± 4 1.9 ± 0.2
a Data from [25,33].
2.3. The Properties of the FMNAT Isoalloxazine Binding Cavity Determines the Binding Mode of Flavinic
Ligands at the FMNAT Module
The lack of FMNAT activity when these residues are substituted by alanine or lysine suggests that
a right coupling of the isoallosazine to its cavity is required for the formation of the catalytic complex,
but does not give us information about whether binding might be fully prevented. To better evaluate
the effect of mutations on the interaction of CaFADS variants with flavin cofactors, we first used
difference spectroscopy in the absence of an adenine nucleotide. In these conditions, FMN and FAD are
reported to exclusively bind at the FMNAT module of the enzyme [26], where the mutations are located.
Incubation with flavins induced the appearance of different spectra for all variants (Figures 5 and 6).
In the case of FMN, variants at F62 produced the most important changes in the shape of the
spectra with regard to the WT enzyme, with redshift of the spectrum and the maximum at 483 nm
becoming a minimum (Figure 5a). However, differences in variants at Y106 and F128 were mainly
observed in the magnitude of the signal, which were significantly lower for substitutions by alanine
and lysine (Figure 5b,c).
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Fig re 5. Internalization of the isoalloxazine ring of FMN in CaFADS variants. Visible difference spectra
elicited with (a) F62, (b) Y106, and (c) F128 CaFADS variants (4–6 µM) upon titration with saturating
FMN concentrations (indicated in parenthesis for each variant). In all panels, the difference spectrum
of WT is included for comparison. Spectra recorded in 20 mM PIPES, 10 mM MgCl2, pH 7.0 at 25 ◦C.
Changes were much more relevant when evaluating the interaction of FAD (Figure 6). Additionally,
in this case, a spectral redshift was observed for F62 variants and, with the exception of F62K, the
magnitude of the signal was considerably reduced (Figure 6a). No difference spectrum was elicited by
the titration with FAD of Y106A, Y106K, F128A, and F128K variants, and, only for F128W, the signal
retained WT shape and intensity (Figure 6b,c). In any case, when binding is produced, all variants
required higher FMN or FAD concentrations for achieving the maximal difference spectra signal.
These observations indicate that the introduced mutations reduce the protein ability to internalize the
isoalloxazine ring of the cofactor within its binding site, which fully prevents it when alanine or lysine
substitute for Y106 or F128.
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i r 6. Internalization of the isoalloxazine ring of FAD in CaFADS variants. Visible differ nce sp ctra
elicited with (a) F62, (b) Y106, and (c) F128 CaFADS variants (4–6 µM) upon titration with saturating
MN co centrations (i dicated in p renthesis for each variant). In all panels, the difference spectrum
of WT is inclu ed for comparison. Specstra recorded in 20 mM PIPES, 10 mM gCl2, pH 7.0 at 25 ◦C.
The thermodynamic parameters for the binding of flavins to CaFADS variants were then determined
by isothermal titration calorimetry (ITC) (Table 3). In the assayed conditions, with 10 mM MgCl2,
FMN and FAD bind at the WT CaFADS FMNAT module with a 1:1 stoichiometry [26], with FAD
binding six-fold stronger than FMN. By contrast, such behavior is inverted in the variants studied in
this res arch, which increases affinity for FMN a decreases it for FAD (Table 3, Figure S4a,b,d,e).
Affinity decreased for both flav ns in F62A. In general, the thermodynamic profiles for the interaction
of flavins also differed from that of the WT. Both the enthalpic and entropic c ntributions for FMN
binding ecrease in magnitude for all variants with the later on becoming favorable (Table S2 d
Figure 7a). In the case of FAD, only subst tu ions by tryptophan kept a similar profile to the WT
enzyme (showi g an important increase in the magnitude of the enthalpic and entropic parameters
for F128W) while the rest o the variants r s mbled e profile observed for the FMN int raction
(Figure 7b). These observatio s confirmed that, wh le mutations at F62, Y106, and F128 do not prevent
the binding of flavins at the FMNAT site of CaFADS, they modify the binding mode of FMN nd FAD
as a consequ nce of the change in the hydro hobic prop rties of the isoalloxazine bindi g cavity.
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Table 3. Interaction parameters as determined for the binding of FMN, flavin adenine dinucleotide
(FAD), and ATP to CaFADS variants. Data obtained by ITC at 25 ◦C in PIPES 20 mM, pH 7.0, at the
indicated MgCl2 concentrations, n = 3, mean ± SD.
Kd FMN (µM) Kd FAD (µM) Kd ATP (µM)
MgCl2 10 mM 10 mM —
WT 7.1 ± 0.4 1.2 ± 0.1 48 ± 7
F62A 15 ± 1 7.9 ± 0.7 44 ± 5
F62K 5.1 ± 0.3 75 ± 3 54 ± 9
F62W 0.8 ± 0.1 5.4 ± 0.1 74 ± 13
Y106A 1.2 ± 0.1 2.6 ± 0.1 31 ± 3
Y106K 0.3 ± 0.1 1.3 ± 0.1 58 ± 13
Y106W 1.7 ± 0.1 6.2 ± 0.2 44 ± 4
F128A 0.4 ± 0.1 14 ± 1 33 ± 3
F128K 0.2 ± 0.1 2.0 ± 0.1 14 ± 1
F128W 0.3 ± 0.1 2.5 ± 0.1 19 ± 1
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2.4. The Hydrophobic Nature of F128 Modulates the Binding Mode of the ATP Substrate
Lastly, we also evaluated the effect of mutations on the binding of ATP. These experiments were
carried out in conditions in which this nucleotide only binds to the FMNAT module in the absence
of MgCl2. As for the WT, all the variants kept the same stoichiometry with one binding site, and, in
general, similar affinity for ATP to that of the WT [26]. Nonetheless, the F128K and F128W substitutions
produced an affinity increase (Kd values 2.5-fold and 3.4-fold lower than the WT) (Table 3, Figure
S4c,d). The interaction of ATP was driven by a positive enthalpic contribution and an opposite entropic
contribution for most variants, similarly to WT, but F128A and F128K variants changed the pattern
(with an important decrease in the enthalpic contribution and the entropic contribution becoming
favorable) (Figure 7c). These results suggest that, from the evaluated residues, only F128 somehow
modulates the conformation of the ATP binding site.
3. Discussion
The FMNAT active site of CaFADS is as an open cavity, coated by residues highly conserved
in prokaryotic FADSs and with a highly hydrophobic cleft as a receptor of the isoalloxazine ring
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of the flavinic substrate (Figures 1 and 2). In this case, we have particularly evaluated the key
role of three hydrophobic and aromatic residues, F62, Y106, and F128, which conform to the
isoalloxazine environment.
Substitutions at F62, Y106, and F128 do not alter the overall CaFADS folding (Figure 3), but
they highly compromise the ability of the enzyme to transform FMN into FAD. Only variants
keeping aromaticity at these positions retain the ability to adenylylate FMN (Figure 4b and Table 1).
Difference spectra and ITC data indicate that variants are able to bind substrates and products of the
FMNAT activity (Figures 5 and 6), but thermodynamic parameters clearly show a general decrease
in the enthalpic contributions to the binding of flavinic substrates in favor of entropic contributions
(Figure 7a,b, and Table S2). Therefore, changes in the aromaticity pattern at the FMNAT cavity hosting
the isoalloxazine decrease the specificity of interactions with flavinic ligands, favoring their binding
through unspecific interactions. Models for the interaction of FMN at the FMNAT site show the
isoalloxazine siting in a hydrophobic pocket contributed by F54, P58, Y106, and F128, stabilized through
a π-stack interaction between the flavinic ring and F62 and an H-bond between its C2 carbonyl and
the hydroxyl of Y106 [12] (Figure 8). In agreement, the near-UV CD spectra indicate that mutations,
independently of the nature of the introduced residue, have a strong effect in conformation of nearby
aromatic residues, and due to the ability and mode of the isoalloxazine binding cavity to locate flavins
(Figures 5a and 6a). Some of the mutations will also considerably alter the surface electrostatic potential
of the cavity, making it less hydrophobic, while the π-stacking and the H-bond would be clearly
disrupted in variants at F62 and Y106, respectively. Altogether, these observations indicate that, despite
the substitutions not preventing the FMNAT site of CaFADS from FMN and FAD recognition, they
have a clear deleterious effect in the competent assembly of their flavinic ring for catalysis. Moreover,
for those variants that still show FMNAT activity, F62W, Y106W, and F128W, parameters indicate
a slower rate for enzyme-substrate complex formation and/or for this complex turning over into a
product during catalysis (Tables 1 and 3). Lastly, only removal of aromaticity at F128 has an effect on
the thermodynamic profiles for ATP binding (Figure 7c and Table S2). The side-chain of F128 does not
point directly to ATP, but it is located at loop L8n next to residues N125 and F126, which, together
with F24, form the binding cavity for the ribose moiety of ATP (Figure 8). The disposition of the
side-chains of F126 and F128 in the WT protein promotes a π-stacking between them. Such stacking
will be disrupted in F126A and F128K variants, where a different conformation can be envisioned for
L8n to influence the ATP binding.
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Figure 8. The FMNAT site of CaFADS. Detail of the catalytic site for the FMNAT activity with FMN
(yellow) and ATP:Mg2+ (magenta) substrates docked according to Reference [12]. P58, F62, Y106, and
F128 (sticks), involved in FMN stabilization, and the structural elements in which they are located
(cartoon) are highlighted in orange. F24, F126, and the catalytic N215 (located at loop L8n), which are
involved in ATP stabilization, are also shown as sticks.
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Comparison of the FMNAT active-site of CaFADS with those of the eukaryotic enzymes carrying
homologous functions revealed clear differences in the properties of the flavin binding cavities as well as
in their binding mode (Figures 1 and 2). While methyl groups of the isoalloxazine are expected to orient
towards the solvent in CaFADS [12], they are buried in eukaryotic enzymes. Thus, the environment
around the isoalloxzine is more hydrophobic in the prokaryotic enzyme, while highly conserved
charged residues contribute to the isoalloxazine site in the eukaryotic counterparts (Figures 1c and 2).
Some of these charged residues, such as D181 in CgFADS and the equivalent D408 in HsFADS, are
crucial residues that contribute to the strong binding of the isoalloxazine of flavins, both as substrates
and products [6,18,35]. In this way, the eukaryotic enzymes modulate their specific activity and the
flavin homeostasis, making the release of the FAD product to the client-apoprotein the limiting step of
the reaction [18,36].
In CaFADS, flavin homeostasis has been related to the formation of a dimer-of-trimers assembly [35].
Mutations at F62, Y106, and F128 also modulate the kinetic parameters for the RFK activity
(Table 2), which is in agreement with overall CaFADS catalysis promoting the formation of such
dimer-of-trimers [28,37]. The formation of this assembly is induced upon binding to the RFK module
of ATP:Mg2+ as well as the products of its activity. In the formed dimer-of-trimers, the RFK module of
one protomer sits on the FMNAT module of the contiguous protomer of the trimer in a head-to-tail
organization that approaches the catalytic sites for FMN and FAD synthesis (Figure S5a). In this
organization, the RFK cavity is partially closed byα2n and L4n of the FMNAT module of the contiguous
protomer (Figure S5b) and the FMNAT cavity is covered by α1c of the adjacent protomer (Figure S5c).
Moreover, crystallographic structures of the independent RFK module free and in complex with FMN
and FMN:ADP revealed how binding of ligands at the RFK module induced conformational changes
at loops L1c and L4c (Figure 9) [9]. Thus, an open binding site for RFK activity alternates with a closed
active site upon binding of ligands. In the context of the trimeric assembly, the close contact between
the RFK and FMNAT modules of contiguous protomers would imply that loop movements at the
RFK module must be accompanied by structural changes at the FMNAT module, especially at α2n
(Figure 9b, down), in order to avoid steric hindrances. The main effects observed by the mutations at
the FMNAT module are decreases of substrate inhibition for the RFK activity of CaFADS [34] which, in
general, result in higher RFK catalytic efficiency. This effect is more remarkable for F62A, F62K, and
F128K variants, which suggests that these mutations nearly prevent the formation of one or several of
the different dead-end complexes related to inhibition of the RFK activity. Furthermore, F62 sits at the
α2n that closes the RF binding site at the RFK module of the contiguous protomer. Its substitution by
alanine or lysine must clearly affect the interaction of RF at the RFK binding site by decreasing the
inhibition produced by this substrate. F128, although far from the RFK active site, is contiguous to
T127, a residue that helps to stabilize the oligomeric structure through an H-bond with E301 of the RFK
module in the contiguous protomer [25]. Changes at F128 could affect the conformation of L8n and,
consequently, the stabilizing interaction T127-E301 (Figure 9b, up). The complexity of the catalytic
mechanism of the bifunctional CaFADS due to the formation of quaternary assemblies and due to the
movements in structural elements during catalysis makes it difficult to assess the implication of these
residues in RFK activity. However, according to the steady-state parameters obtained for this activity,
its relevance is clear.
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In conclusion, F62, Y106, and F128 play a key role in the competent binding of FMN and FAD
at the FMANT site of CaFADS by providing a hydrophobic cavity that specifically recognizes their
isoalloxazine rings. Together with a recent work involving residues P56, P58, and L98 at the entrance
of the isoalloxazine cavity (Figure 2a) [30], this study also confirms that, in CaFADS, the isoalloxazine
binding mode is specific for the formation of the catalytic complex with the flavin and adenine
substrates as well as their transformation into the reaction products. Despite its apparently open and
broad active-site, the FMNAT module of prokaryotic CaFADS confers a reaction specificity through a
hydrophobic nature (provided by F62, Y106, and F128) and the shape (given by P56, P58, and L98)
of its isoalloxazine binding site. In addition, this site’s results are different enough from eukaryotic
FADSs to be considered a drug target for evelo i g ote tial antimicrobials. Moreover, the results
provide new evidence of the crosstalk between the RFK and FMNAT activities for regulating FMN and
FAD biosynthesis by forming quaternary organiz tions, which s a mechanism not described for any
other prokary tic FADSs nor for eukaryotic FMNATs.
4. Materials and Methods
4.1. Biological Material
pET28a-CaFADS plasmids containing the F62A, F62K, F62W, Y106A, Y106K, Y106W, F128A, F128K,
and F128W mutations were obtain d fr m Mutagenex®. Proteins were over-expressed in BL21(DE3) E.
coli cells and purified, as previously described [30,34] with 20% ammonium fractionation, which is
followed by phenyl-sepharose and DEAE-cellulose chromatography and, then, di lyzed in 20 mM
PIPES pH 7.0. Protein purity was assessed by SDS-PAGE.
4.2. Spectral Analysis
Spectroscopic measure e in a ary-4 0 spectrophotom ter (Agilent
Technol gies, Santa Clara, CA, S ). i coefficients in 20 mM PIPES, pH 7.0 at 279 nm
(ε279) were calculated base f i l and von Hi pel [38]. The UV-v sible spectra of the
folded enzymes and, after being denatured with guanidinium hydrochloride (6 M Gdn/HCl in 20 mM
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sodium phosphate, pH 6.5), were recorded. The extinction coefficient of the proteins in their denatured
state, obtained from their amino-acid sequences, was used to calculate the concentration of the sample.
Then, this concentration, taking into account the dilution during denaturation, was used to determine
the ε279 in 20 mM PIPES, pH 7.0 from the Beer-Lambert law.
Difference spectroscopy measurements were carried out in 20 mM PIPES, 10 mM MgCl2, pH 7.0
with ~4–6 µM CaFADS, and the saturating concentrations of ligands were determined for each variant.
CD spectra were recorded in a Chirascan spectropolarimeter (Appl. Phot. Ltd., Leatherhead,
Surrey, UK) at 25 ◦C. Samples containing 5 µM CaFADS in 5 mM PIPES, 10 mM MgCl2, pH 7.0, and
20 µM CaFADS in 20 mM PIPES, 10 mM MgCl2, pH 7.0 were used in the far-UV CD (path length,
0.1 cm) or near-UV CD (path length, 0.4 cm), respectively. The spectra were analyzed to determine the
percentage of secondary structural elements with the CDPro programs SELCON3 [39], CDSSTR [40],
and CONTINLL [41].
4.3. Qualitative Detection of RFK and FMNAT Activities
RFK and FMNAT activities were qualitatively assayed by separation of flavins from reaction
mixtures by TLC on Silica Gel SIL-G-25 plates (20 × 20 cm, thickness 0.25 mm), as previously
described [7,29]. The reaction mixtures containing 50 µM RF/FMN, 0.2 mM ATP, 10 mM MgCl2, and
~200 nM of CaFADS in 20 mM PIPES, pH 7.0 were incubated for 30 min and 2 h at 37 ◦C. Reactions
were stopped by boiling the preparations for 5 min. Flavin spots were visualized under UV light.
4.4. Steady-State Kinetics Parameters for RFK Activities
The RFK and FMNAT activities were measured at 25 ◦C in 500 µL of 20 mM PIPES, pH 7.0 with
0.8 mM MgCl2 and 10 mM MgCl2, respectively. Reaction containing 0.5–55 µM RF or 0.2–150 µM
FMN and 10–500 µM ATP were initiated by adding the enzyme (~20 nM). After 1 min of incubation at
25 ◦C, the reactions were stopped by boiling the mixtures for 5 min. The flavin composition in the
supernatant was determined by using an Alliance high-performance liquid chromatography (HPLC)
system (Waters, Milford, MA, USA) equipped with a 2707 autosampler and an HSST3 column (4.6 ×
150 mm, 3.5 µm, Waters). This is preceded by a pre-column (4.6 × 20 mm, 3.5 µm, Waters). Flavins
(FMN or FAD) produced from RF were quantified through their corresponding standard curves, as
previously described [29].
The kinetic data (from triplicate experiments) obtained for one substrate at saturating
concentrations of the second one (as nmol of flavin transformed per min) were fitted to the
Michaelis-Menten kinetic equation (Equation (1)) or to the equation that describes the substrate















where kcat is the catalytic constant, Km is the Michaelis-Menten constant, and Ki is the inhibition
constant. Errors for the kcat and Km values were of ±10% for Michaelis-Menten models while, in
the case of substrate inhibition, errors in apparent Km and kcat (appKm and appkcat) increased with an
inhibition constant (Ki) getting closer to KmS.
4.5. Isothermal Titration Calorimetry (ITC)
Measurements were carried out using a VP-ITC microcalorimeter (MicroCal LLC, Northampton,
MA, USA) thermo-stated at 25 ◦C. Ligand (200 µM FMN or FAD and 300 µM ATP) and enzymes
(~20 µM of CaFADS) were dissolved in 20 mM PIPES, pH 7.0 (in presence of 10 mM MgCl2 for the
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flavins), and degassed prior to titration. Up to 28 injections of 4 µL of ligand were added to the sample
cell (1.4109 mL) containing the enzyme and mixed via the rotating (1000 rpm) stirrer syringe.
The association constant (Ka), the enthalpy change (∆H), and the stoichiometry (N) were obtained
through non-linear regression of the experimental data to a home-derived model for one or two
independent binding sites implemented in Origin 7.0 (OriginLab, Northampton, MA, USA) [7,29]. The
dissociation constant (Kd), the free energy change (∆G), and the entropy change (∆S) were obtained
from basic thermodynamic relationships. Experiments were performed in duplicate or triplicate. Errors
in the measured parameters (±15% in Kd and ±0.3 kcal/mol in ∆H and –T∆S parameters) were taken
as larger than the standard deviation between replicates and the numerical error after fitting analysis.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/11/3738/s1,
Figure S1: Conformation of CaFADS mutants, Figure S2: Kinetic parameters for the FMNAT and RFK activities
of the CaFADS variants, Figure S3: Internalization of the isoalloxazine ring of FMN in CaFADS variants, Figure
S4: Internalization of the isoalloxazine ring of FAD in CaFADS variants, Figure S5: Binding affinity of ligands to
WT and F128K CaFADS variants, Figure S6: Quaternary assembly of CaFADS (PDB 2x0k), Table S1: Extinction
coefficients for the CaFADS variants, Table S2: Thermodynamic parameters for the interaction of CaFADS variants
with flavin and adenine nucleotides.
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